From the May 2024 issue of UCLA Health's Healthy Years (HY)
New FDA-Approved Drug for Ovarian Cancer

You are trying to access subscriber-only content.
If you are a subscriber,
.If you are not a subscriber, or are only subscribed to the print edition, click here to subscribe now. Digital subscribers have unlimited access to our magazine articles and more!
Ovarian cancer, notoriously difficult to treat, has seen little advancement in treatment, with most cases diagnosed at advanced stages and a survival rate of about 50% beyond five years. The UCLA Health women’s cancer research team aims to change this by developing new treatments for ovarian cancer and other gynecologic malignancies. A breakthrough came with […]